Fatemeh Seyednasrollah

发表

ROTS: reproducible RNA-seq biomarker detector—prognostic markers for clear cell renal cell cancer

L. Elo, Fatemeh Seyednasrollah, K. Rantanen, 2015, Nucleic acids research.

Prediction of Adulthood Obesity Using Genetic and Childhood Clinical Risk Factors in the Cardiovascular Risk in Young Finns Study

Fatemeh Seyednasrollah, Laura L Elo, Terho Lehtimäki, 2017, Circulation. Cardiovascular genetics.

Reproducibility-optimized detection of differential DNA methylation.

L. Elo, Fatemeh Seyednasrollah, B. Ghimire, 2020, Epigenomics.

End-of-life chemotherapy use at a Finnish university hospital: a retrospective cohort study

L. Elo, Fatemeh Seyednasrollah, J. Mäkelä, 2017, Acta oncologica.

Assessing the utilization of radiotherapy near end of life at a Finnish University Hospital: a retrospective cohort study

L. Elo, H. Minn, Fatemeh Seyednasrollah, 2017, Acta oncologica.

A DREAM Challenge to Build Prediction Models for Short-Term Discontinuation of Docetaxel in Metastatic Castration-Resistant Prostate Cancer

Stephen R. Piccolo, Luke N. Kumar, R. Greiner, 2017, JCO clinical cancer informatics.

Re: Fatemeh Seyednasrollah, Mehrad Mahmoudian, Liisa Rautakorpi, et al. How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer? Eur Urol. 2017;71:838–40

Fatemeh Seyednasrollah, Mehrad Mahmoudian, Liisa K. Rautakorpi, 2017 .

Reply to Tuomas Mirtti and Tero Aittokallio's Letter to the Editor re: Fatemeh Seyednasrollah, Mehrad Mahmoudian, Liisa Rautakorpi, et al. How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer? Eur Urol. 2017;71:838-40. Clinical Ut

L. Elo, Fatemeh Seyednasrollah, Mehrad Mahmoudian, 2017, European urology.

How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer?

L. Elo, Fatemeh Seyednasrollah, Mehrad Mahmoudian, 2017, European urology.

A community-based collaboration to build prediction models for short-term discontinuation of docetaxel in metastatic castration-resistant prostate cancer

Stephen R. Piccolo, Luke N. Kumar, R. Greiner, 2016, bioRxiv.

Simultaneous Ozone and High Light Treatments Reveal an Important Role for the Chloroplast in Co-ordination of Defense Signaling

Fatemeh Seyednasrollah, M. Brosché, M. Tikkanen, 2022, Frontiers in Plant Science.

DREAM Community. Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial

Stephen R. Piccolo, Suleiman A. Khan, Luke N. Kumar, 2016 .

ROTS: An R package for reproducibility-optimized statistical testing

Maria K. Jaakkola, Laura L. Elo, Fatemeh Seyednasrollah, 2017, PLoS Comput. Biol..

Comparison of software packages for detecting differential expression in RNA-seq studies

Laura L. Elo, Fatemeh Seyednasrollah, Asta Laiho, 2013, Briefings Bioinform..

Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high HIF2A mRNA levels in clear cell renal cell carcinoma

L. Elo, Fatemeh Seyednasrollah, K. Rantanen, 2019, The Journal of Biological Chemistry.

Comparison of methods to detect differentially expressed genes between single-cell populations

Maria K. Jaakkola, Laura L. Elo, Fatemeh Seyednasrollah, 2016, Briefings Bioinform..

A predictive model of overall survival in patients with metastatic castration-resistant prostate cancer

L. Elo, Fatemeh Seyednasrollah, Mehrad Mahmoudian, 2016, F1000Research.

A predictive model of overall survival in patients with metastatic castration-resistant prostate cancer.

L. Elo, Fatemeh Seyednasrollah, Mehrad Mahmoudian, 2016, F1000Research.

A DREAM challenge to build prediction models for short-term discontinuation of docetaxel in metastatic castration- resistant prostate cancer

Stephen R. Piccolo, Luke N. Kumar, R. Greiner, 2017 .